Antitachycardia pacemakers and implantable cardioverter defibrillators (ICD) were
implanted in 14 patients to control recurrent hemodynamically stable ventricular tachycardia …

BACKGROUND--The availability of implantable cardioverter-defibrillators (ICD) that are
capable of antitachycardia pacing may lead to an increased use of ICDs in patients with …

This article describes our experience with an antitachycardia pacemaker alone (N= 3) or in
combination with an automatic implontoble cardioverter defibrillator (AICD, N= 8) in the …

Antitachycardia pacing for ventricular tachycardia (VT) is associated with the possibility of
fibrillating the heart; on the other hand,(he frequency of VT and patient discomfort can limit …

Objectives. This study was conducted to assess the effectiveness of antitachycardia pacing
modes and detection algorithms in patients with a new third-generation implantable …

Twenty patients (aged 50±21 years and mean left ventricular ejection fraction 37±17%) with
recurrent ventricular arrhythmias were treated with an investigational, implantable combined …

Antitachycardia pacing in ventricular tachyarrhythmias (VT) is associated with potential
acceleration of VT: frequency of VT and discomfort of the patient (pt) can limit treatment with …

Chronic recurrent ventricular tachycardia (VT) can be terminated reproducibly by
programmed endocardial right ventricular stimulation. However, antitachycardia pacing is …

Focuses on the antitachycardia pacing for ventricular tachycardia. Use of implantable
cardioverter defibrillators on ventricular tachycardia; Pathophysiological basis for sustained …

The purpose of this study was to determine the termination and acceleration rates for 1 to 6
attempts of antitachycardia pacing (ATP) delivered by ICD in order to terminate …